Anika Therapeutics, Inc. (ANIK)
Largest Insider Buys in Sector
ANIK Stock Price History Chart
ANIK Stock Performance
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide …
Insider Activity of Anika Therapeutics, Inc.
Over the last 12 months, insiders at Anika Therapeutics, Inc. have bought $0 and sold $0 worth of Anika Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Anika Therapeutics, Inc. have bought $274,901 and sold $185,436 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,500 shares for transaction amount of $32,055 was made by Colleran David (EVP, General Counsel, Corp Sec) on 2022‑05‑11.
List of Insider Buy and Sell Transactions, Anika Therapeutics, Inc.
| 2022-05-11 | EVP, General Counsel, Corp Sec | 1,500 0.0104% | $21.37 | $32,055 | +22.64% | |||
| 2022-03-14 | EVP, General Counsel, Corp Sec | 1,500 0.0109% | $26.65 | $39,978 | -3.85% | |||
| 2022-03-11 | President, CEO, Director | 3,813 0.0266% | $25.81 | $98,429 | -4.61% | |||
| 2022-03-11 | 2,000 0.0133% | $24.66 | $49,318 | -4.61% | ||||
| 2022-03-11 | EVP, CFO, Treasurer | 4,000 0.0266% | $24.62 | $98,476 | -4.61% | |||
| 2021-08-12 | EVP, CFO, Treasurer | 777 0.0053% | $40.20 | $31,239 | -23.48% | |||
| 2021-08-11 | EVP, CFO, Treasurer | 2,850 0.0196% | $40.21 | $114,587 | -22.71% | |||
| 2021-05-18 | director | 2,000 0.014% | $42.86 | $85,720 | -6.92% | |||
| 2021-05-12 | Sale | director | 2,000 0.014% | $42.60 | $85,200 | -5.92% | ||
| 2020-11-10 | Sale | director | 3,446 0.0232% | $36.77 | $126,709 | +6.14% | ||
| 2020-07-09 | Sale | EVP Business Development | 1,244 0.0089% | $35.15 | $43,727 | +8.80% | ||
| 2020-02-26 | Sale | director | 2,700 0.0192% | $42.68 | $115,236 | -13.87% | ||
| 2019-11-08 | Sale | Chief Financial Officer | 20,000 0.1389% | $59.71 | $1.19M | -39.44% | ||
| 2019-08-28 | Sale | director | 4,355 0.031% | $57.21 | $249,150 | -27.63% | ||
| 2019-08-20 | Sale | director | 1,994 0.0141% | $55.57 | $110,807 | -24.80% | ||
| 2019-08-08 | Sale | director | 4,843 0.0345% | $56.66 | $274,404 | -24.77% | ||
| 2019-07-29 | Sale | director | 3,000 0.0222% | $55.44 | $166,320 | -17.75% | ||
| 2019-02-28 | President and CEO; Director | 1,000 0.0072% | $33.20 | $33,200 | +38.89% | |||
| 2019-02-26 | Sale | director | 4,000 0.0287% | $33.06 | $132,240 | +39.32% | ||
| 2017-11-30 | Sale | Chief Commercial Officer | 5,250 0.0356% | $54.48 | $286,020 | -23.46% |
Insider Historical Profitability
| Blanchard Cheryl R | President, CEO, Director | 59992 0.4096% | $17.42 | 1 | 0 | <0.0001% |
| QUINLAN KEVIN W | Chief Financial Officer | 27112 0.1851% | $17.42 | 5 | 2 | +3.86% |
| Darling Joseph G | President and CEO; Director | 22436 0.1532% | $17.42 | 1 | 0 | +38.89% |
| Thompson Jeffery S | 17121 0.1169% | $17.42 | 1 | 4 | <0.0001% | |
| Levitz Michael L | EVP, CFO, Treasurer | 15924 0.1087% | $17.42 | 3 | 0 | <0.0001% |
Institutional Investor Ownership
| Trigran Investments, Inc. | $52.64M | 13.98 | 2.07M | -3.12% | -$1.69M | 5.1 | |
| BlackRock | $39.65M | 10.53 | 1.56M | +12.81% | +$4.5M | <0.01 | |
| Caligan Partners LP | $36.47M | 9.68 | 1.44M | +32.8% | +$9.01M | 9.64 | |
| Dimensional Fund Advisors | $20.57M | 5.46 | 809,755 | -1.42% | -$297,103.80 | 0.01 | |
| The Vanguard Group | $19.65M | 5.22 | 773,702 | +1.26% | +$245,287.80 | <0.0001 |